Clinical Trials Logo

Nasal Polyps clinical trials

View clinical trials related to Nasal Polyps.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 3

NCT ID: NCT04267042 Not yet recruiting - Clinical trials for Chronic Rhinosinusitis With Nasal Polyps

Comparing Budesonide Via MAD or INSI Prospective Cohort Study

Start date: February 3, 2020
Phase: Early Phase 1
Study type: Interventional

Chronic Rhinosinusitis (CRS) is a common disorder in North America, affecting more than 31 million people annually. Common therapy for CRS includes intranasal corticosteroids (INCS) such as budesonide. At our centre , the current practice is to administer budesonide two ways: the mucosal atomization device (MAD), which is a nasal spray or impregnated budesonide in nasal saline irrigation (INSI), which is a nasal rinse. Our study aims to see which method of administering budesonide has the best treatment outcomes after sinus surgery. This study will follow patients over a six-month period of time.

NCT ID: NCT04105361 Not yet recruiting - Nasal Polyps Clinical Trials

Impact of Posterior Nasal Neurectomy With Functional Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyposis:A Comparative Study

Start date: January 2020
Phase: N/A
Study type: Interventional

The study will be conducted to investigate the efficacy of posterior nasal neurectomy in control of recurrence and improvment of allergic symptoms in patients with allergic rhinitis combined with nasal polyposis

NCT ID: NCT03607175 Not yet recruiting - Nasal Polyps Clinical Trials

Adjunctive Treatment for Chronic Rhinosinusitis With Nasal Polyposis

Start date: July 24, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

This is a research study to find out if an off-label use of carboxymethylcellulose foam (CMC), an absorbable nasal packing, combined with triamcinolone acetonide, a steroid, is more comfortable postoperatively for participants and is as effective in decreasing scarring, swelling and crusting after surgery than an FDA approved steroid eluting implant. Anticipated sample size will be 30. Study is an intrapatient control design. Subjects will be randomly assigned to receive CMC foam with triamcinolone in one nare and the steroid-eluting implant in the other. Participants will fill out preoperative and follow-up visit surveys at 7, 14, 30 and 90 days. Subjects at each visit will also have pictures taken of the nasal cavities to be scored for later analysis. Paired t-tests will be performed for analysis. Our primary objective is to demonstrate that triamcinolone-impregnated carboxymethylcellulose foam is noninferior to steroid-eluting implants in improving postoperative ethmoid inflammation, middle turbinate position, preventing intranasal synechiae and reducing polypoid change with objective measurement scales Our secondary objects include assessing the quality-of-life and nasal obstruction symptoms before and after functional endoscopic sinus surgery with validated SNOT-22 and NOSE questionnaires and to assess the cost-effectiveness of triamcinolone-impregnated carboxymethylcellulose foam versus steroid-eluting implant in management of CRSwNP in the early postoperative period. The endpoints are the POSE scores, the SNOT-22 and NOSE scores at days 7, 14, 30 and 90.

NCT ID: NCT01681615 Not yet recruiting - Clinical trials for Asthma, Aspirin-Induced

Challenge Test for Acetylsalicylic Acid Hypersensitivity

Start date: September 2012
Phase: N/A
Study type: Interventional

The investigators want to find new challenge test for Acetylsalicylic hypersensitivity / Aspirin hypersensitivity. The investigators suggest that this new test will be as efficient as the already established protocols in terms of sensitivity and specificity.

NCT ID: NCT01013701 Not yet recruiting - Clinical trials for Patients With Nasal Polyps

Compare the Effects of Fluticasone Furoate Nasal Spray vs Placebo in Patients With Nasal Polypoid Disease

Start date: November 2009
Phase: Phase 4
Study type: Interventional

Fluticasone furoate is being studied to determine whether treatment with a topical nasal steroid, in patients with existing nasal polyps , can not only improve symptoms but also suppress the recurrence of clinically significant nasal polyp obstruction and prevent surgical intervention.